Related Experiment Videos
Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study
E J Tilchen1, T Fleming, G Mills
1Henry Ford Hospital, Detroit, MI.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.
European annals of otorhinolaryngology, head and neck diseases·2026
Vestibulectomy prior cordectomy in tomes: Advantages and dysplasia findings.
European annals of otorhinolaryngology, head and neck diseases·2025
Chain Reduction of CHCl3 Photocatalyzed by SPEEK/PVA Films Swollen in Air-Saturated HCO2Na Solutions.
Materials (Basel, Switzerland)·2023
Informed consent in dentistry and medicine in Spain: Practical considerations and legality.
Medicina oral, patologia oral y cirugia bucal·2022
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder.
Neuroscience and biobehavioral reviews·2026
Molecular landscape of chondrosarcoma: From tumor biology to therapeutic vulnerabilities.
Biochimica et biophysica acta. Reviews on cancer·2026
Development and implementation of a standardized audit tool for cytotoxic drug preparation practices in oncology.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
PET imaging enables direct evaluation of ferroptosis in HCC synergistically induced by anti-PD-L1 and Olaparib.
Experimental & molecular medicine·2026